Autoantibodies targeting myelin oligodendrocyte glycoprotein (anti-MOG-IgG) are a marker of several central nervous system inflammatory demyelinating disorders, including ADEM, bilateral optic neuritis, transverse myelitis, and brainstem encephalitis. The gene discussed is MOG; the disease is acute disseminated encephalomyelitis.